- Valeo Health raised USD 12M in Series B funding led by Flintera, with participation from Nuwa Capital, FJ Labs, and Oryx.
- Funds will support GCC expansion and AI scaling, enhancing product offerings, personalized healthcare services, and wellbeing solutions.
- Founded by Sundeep Sahni, Nadine Karadag, and Ankur Mujunder, Valeo offers AI-driven health tracking, at-home tests, and personalized wellbeing coaching.
Valeo Health
What happened? Valeo Health raised USD 12 million in a series B funding round. The round was led by Flintera and included participation from Nuwa Capital, FJ Labs, Oryx, and Mindshift Capital. Additionally, there was also participation from Oraseya and Eirad.
What will they do with the funds? With the newly acquired capital, Valeo plans to use the funds to expand its services in Saudi Arabia, UAE and other GCC countries. In addition, it aims to scale its AI technology, enhance its products and expand reach.
“This funding enables us to scale our AI technology, enhance our product offerings, and expand our reach, ensuring more individuals benefit from proactive healthcare solutions.” said Sundeep Sahni, CEO & Co-Founder of Valeo Health.
Who are they? Founded by Sundeep Sahni, Nadine Karadag,and Ankur Majumder, Valeo Health is a healthtech company that specializes in AI-driven personalized healthcare. Furthermore, it provides at-home healthcare services and personalized treatments using AI technology.
The founders saw a gap in the market with little attention paid to those who are not sick but are not feeling their best. To solve this, Valeo launched a personalized health tracking and guided wellbeing app. Moreover, the app enables users to schedule at home wellbeing tests, get advice on their results and connect with certified wellbeing coaches.
Previous Funding
Previous Funding Rounds It is worth noting that in 2021, Valeo Health raised USD 3 million in a seed funding round. At this point, it aimed to use the funds to scale the platform and launch new wellbeing products in the local market. It also planned to expand to other GCC markets.
If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.
